Caricamento...
Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells
Anti-angiogenic therapy is an important strategy to limit growth, development and expansion of solid tumors. However, resistance to VEGF-targeting agents may develop, due to activation of alternative pro-angiogenic pathways, indicating the need of multiple target strategy. Here we obtained tumor end...
Salvato in:
| Pubblicato in: | Oncotarget |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Impact Journals LLC
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5978257/ https://ncbi.nlm.nih.gov/pubmed/29854307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25206 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|